What one share of Positron holds
Nature of Business. Positron is a medical technology company that co-develops, manufactures and sells PET and PET-CT imaging systems, delivering high-performance, cost-effective molecular imaging solutions that empower healthcare providers to improve the diagnosis and treatment of cardiovascular disease and other critical conditions.
Positron’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $0.01 |
|---|---|
| Profit | −$0.31 |
| Cash and investments | $0.01 |
| Debt | $0.00 |
| Book value | −$0.02 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2024 | $0.02 | −$0.09 | — | — | — | −$0.02 |
| 2025 | $0.01 | −$0.34 | — | — | — | $0.04 |
Common questions about Positron
How much does one share of Positron earn?
Over the last 12 months, Positron lost $0.31 for each share on $0.01 of sales.
Does Positron pay a dividend?
Positron didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Positron’s book value per share?
Positron’s book value is negative (−$0.02 per share): it owes more than everything it owns is recorded at, often after years of buying back its own shares, as of June 30, 2026.
How much cash and debt does each share of Positron have?
Each share of Positron has $0.01 of cash and investments and $0.00 of debt, as of June 30, 2026.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.